Legal status by country
Is Bradykinin legal?
Written by Aaron CuhaReviewed Sep 2026
How Bradykinin is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | There is no bradykinin medicinal product. It is used as a research reagent and as a provocation agent in physiology studies conducted under research protocols. | None recorded | None recorded | None recorded |
US FDA status: Not an approved drug. Bradykinin is an endogenous mediator and a laboratory reagent; no bradykinin product appeared in the Drugs@FDA checks run for this batch. The approved medicine acting on this system is the B2 receptor antagonist icatibant.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.